Strategy
Pharmaceutical Marketing
Strategies for Asia Pacific
Development of meaningful and cohesive marketing strategies in Asia is one of the hottest topics in the pharmaceutical industry today Multinational pharmaceutical companies are increasingly looking to Asia to drive sales growth Marketing is simultaneously recognised by the industry as vital for product success and derided by the media as the main r...
Shaping the Future of Drug Development & Marketing Strategies
Payer perspectives
The US ranks th in the world in life expectancy and th in infant survival rates Virtually all the statistics point in the same direction Compared to other developed nations health outcomes in the US are worse and costs are higher US health outcomes and costs are unacceptable For example the US ranked last out of developed nations in a study of...
Rethinking R&D
Novel approach to partnering
Like the majority of industries in todays economy the pharmaceutical industry faces a range of business challenges The number of new drug approvals in was the lowest in almost a quartercentury and was only slightly higher A continuing increase in patent expirations would result in a projected US billion loss in revenue by With a decrease in...
International Strategic Alliances
Positioning the Asian biotechnology company
Strategic alliances and partnering between biotechnology companiesat all stages of their developmentand established pharmaceutical companies have characterised the biotechnology industry since its inception Many companies in the US and Europe have accumulated the experience in developing relationships executing transactions and delivering completed...
Generic to Innovative
Transition of Indian pharmaceutical companies
Not many people recall that India remained a net importer of pharmaceutical products until Table The s witnessed a marked departure and saw India emerging as a major supplier of generics to the world The situation changed rapidly thereafter By Indias exports grew tenfold to US million as against imports of US million generating a trade surplus...
New Drugs in Anaesthesia
Catering to new demands
The history of anaesthesia mentions use of nonpharmacological Cold Concussion Carotid compression Nerve compression Blood letting and Hypnosis and pharmacological techniques use of alcohol opium hyoscine cannabis cocaine in ancient and mediaeval times for anaesthesia onwards as anaesthesia became popular more and more surgeries were carried out...
SAP ERP Implementation Strategy & Validation Activity Before Implementation in Pharma / Biopharma Business
The Pharma industry operates under drug regulations imposed by various drug administrations This necessitates continuous monitoring and tracking A high profile ERP package is essential to meet this requirement For monitoring online activity and to ensure Good Manufacturing Practices it is necessity to implement electronic documentation generation a...
Liver Cancer Treatment in Asia
From little acorns
Increasing competition in the oncology space is heightening the importance of marketing competence and impacting decisions made long before a product enters the market Assuming proven favourable efficacy and toxicity across a number of potential areas choosing the right point of entry for a molecule is critical given that some indications will be s...
Anticipating the Future
Biorepositories hold the key
The first complete human genome sequence was published in and laid the foundation for a more comprehensive understanding of human disease When this sequence was published many felt as though the era of personalised medicine was around the corner and that pharmaceutical companies should embrace this new knowledge to better design personalised the...
2012 and beyond
What lies ahead
One thing is for certain todays pharmaceutical marketplace is punctuated by change and uncertainty The pharmaceutical industry is facing a tough road ahead in the future market place Major products are facing patent expiry and pipelines are not replacing the ageing products Approvals of NMEs continue to decline while development and commercialisati...
